Name: measuring ascending aortic stiffness in vivo in mice using ultrasound
Uploaded: 2014-12-02T12:00:00.000+00:00
Duration: 10 min 8 s
Description: Watch this Scientific Journal Video about Measuring Ascending Aortic Stiffness In Vivo in Mice Using Ultrasound at JoVE.com

This work was supported by a National Heart, Lung, and Blood Institute grant 1RO1-HL-105296-01 (to D.E. Berkowitz) and an Australian Research Council Grant DP110101134 (to A. Avolio).

This protocol has been approved by the Institutional Animal Care and Use Committee at Johns Hopkins University.
1. Preparation of Solutions, Materials, and Animal
<ol>
	<li>Prepare a 300 &#181;g/ml solution of phenylephrine (PE) and 300 &#181;g/ml solution of sodium nitroprusside (SNP) in 0.9% saline. Prepare a separate heparin-saline solution by mixing 1 ml of 1,000 U/ml heparin into 10 ml of 0.9% saline. 
	NOTE: Drugs should be at room temperature before use.</li>
	<li>Make the catheter for intravenous drug infusion from two 30 G x &#189;&#8221; hypodermic needles and PE 10 polyethylene tubing. To make the catheter, insert one needle into one end of the tubing. Remove the needle portion of the other hypodermic needle and insert the blunt end into the other end of the tubing. Attach the catheter to a 1 ml syringe and fill the catheter with the heparin-saline solution.</li>
	<li>Place mouse in the anesthesia induction chamber containing 2-2.5% isoflurane in 100% oxygen. Leave the mouse in the induction chamber until it is unresponsive to external stimuli.</li>
	<li>Remove the mouse from the induction chamber and place it on the heated electrocardiogram (ECG) pad. Maintain the animal at 2% isoflurane.</li>
	<li>Apply vet ointment or saline solution to the animal&#8217;s eyes to prevent dryness during the procedure.</li>
</ol>
2. Insertion of Catheter into Tail Vein
<ol>
	<li>Since the tail veins are located laterally on both sides of the tail, place the animal on its side for better access. Secure the mouse onto the ECG pad with tape. Make sure the animal is kept warm to promote vasodilation of the tail veins.</li>
	<li>Using a piece of silastic tubing as a tourniquet, tie the tourniquet around the base of the tail. Tie the tourniquet tight enough to collapse the veins but not enough to cut off the arterial circulation. After 2-3 min, the vein should bulge out and become more visible.</li>
	<li>Gently pull the tail taut. Bend the tail at an angle with one hand and hold the needle parallel to the tail with the other. Pierce the needle where the tail is bent through the skin into the vein. Blood will push back into the catheter if the needle is inserted into the vein.</li>
	<li>Place one drop of tissue glue where the needle is inserted to secure the catheter. Remove the tourniquet and confirm patency by injecting saline with little resistance.</li>
</ol>
3. Insertion of Blood Pressure Catheter through Femoral Artery
<ol>
	<li>Place the pressure catheter into a 30 ml syringe filled with distilled water and connect the catheter to the pressure control unit. Soak the catheter in water, plugged in, for 30-45 min during the set-up and surgery procedures.</li>
	<li>Place the animal supine and tape its paws onto the ECG pad. Apply depilatory cream on the chest and area over the femoral artery.
	<ol>
		<li>Wait 3-5 min and remove cream and hair. Thoroughly remove hair from the chest to prevent artifacts during the ultrasound. Wipe both the chest and hind limb regions with a moistened pad to remove excess depilatory cream.</li>
	</ol>
	</li>
	<li>Using fine scissors, make an incision in the skin above the location of the femoral artery. Dissect through the subcutaneous fat tissue to reveal the femoral artery. The femoral artery is partially covered by the abdomen. Use hemostats to move the abdomen away.&#160;Keep the tissues moist by covering it with moist gauze or alternatively dripping saline over it periodically to prevent tissues from drying out.&#160;</li>
	<li>Using fine forceps, separate the nerve away from the artery-vein bundle. Gently pierce through the sheath around the artery-vein bundle to separate the artery from the vein. Pass one suture around the artery at the proximal end and place two sutures at the distal end.</li>
	<li>Securely knot the most distal suture to stop distal blood flow. Use hemostats to pull the proximal suture to temporarily stop blood flow into the femoral artery. Use microscissors to make a small incision into the femoral artery. Make the incision near the distal knot.</li>
	<li>Calibrate the data acquisition software to the catheter using the calibration settings on the pressure control unit. Switch the pressure control unit back to reading the transducer and balance the pressure catheter so that the catheter outputs 0 mm Hg in the water filled syringe.</li>
	<li>Insert the catheter into the femoral artery. Open the incision with fine forceps with one hand and insert the catheter head into the artery with the other hand.
	<ol>
		<li>Knot the middle suture around the catheter wire to secure the catheter into the artery. Relax the proximal suture and advance the catheter forward into the abdominal aorta. Knot the proximal suture to further secure the catheter and to prevent bleeding.</li>
	</ol>
	</li>
	<li>Carefully move the ECG pad with mouse, pressure catheter and saline syringe to the ultrasound imaging stage. Connect the blood pressure catheter to the pressure control unit. Place the saline syringe in the syringe pump. Allow the animal and the catheter to equilibrate for 20 min.</li>
</ol>
4. Measuring Aortic Diameter Over a Range of Blood Pressures
<ol>
	<li>Reduce isoflurane to 1.5%. Visualize the ascending aorta longitudinally on B-mode using a long axis view. Mount the transducer onto the rail system so that the same view is maintained for the duration of the experiment.</li>
	<li>On the ultrasound mainframe, place the M-mode cursor over the section of aorta to be tracked. Track the aortic diameter change over the cardiac cycle using M-mode.</li>
	<li>Change the saline in the syringe to the PE solution and place the syringe into the syringe pump.
	<ol>
		<li>Record M-mode at baseline aortic pressure. Begin infusion at 360 &#181;g/kg/min and infuse for 1 min for aortic pressure to reach a plateau. For a 25 g mouse, this dose equates to 30 &#181;l/min.</li>
		<li>Record the M-mode, then stop the infusion, and wait 2 min for blood pressure to return to baseline.</li>
	</ol>
	</li>
	<li>Lower infusion rate to 240 &#181;g/kg/min. For a 25 g mouse, this dose equates to 20 &#181;l/min. Start infusion, infuse for 1 min for blood pressure to plateau, and record M-mode. Stop the infusion, and wait 2 min for blood pressure to return to baseline.</li>
	<li>Repeat step 4.4 for 120 &#181;g/kg/min PE (10 &#181;l/min for a 25 g mouse).</li>
	<li>Replace PE with saline and infuse the saline at the rate used for the 360 &#181;g/kg/min infusion (30 &#181;l/min for a 25 g mouse). Infuse for 2-3 min, until further infusion does not produce an increase in aortic pressure and pressure is returning to baseline. Wait 5 min for the blood pressure to stabilize at baseline.</li>
	<li>Replace saline with SNP.
	<ol>
		<li>Record M-mode at baseline aortic pressure. Begin infusion at 240 &#181;g/kg/min (20 &#181;l/min for 25 g mouse)and infuse for 1 min. When aortic pressure reaches a plateau, record the M-mode. Stop the infusion and wait 2 min for blood pressure to return to baseline.</li>
	</ol>
	</li>
	<li>Lower infusion rate to 120 &#181;g/kg/min (10 &#181;l/min for 25 g mouse). Start infusion, infuse for 1 min for blood pressure to plateau, and record M-mode. Stop infusion and wait 2 min for blood pressure to return to baseline.</li>
	<li>Repeat step 4.8 for 60 &#181;g/kg/min SNP (5 &#181;l/min for 25 g mouse).</li>
</ol>
5. Terminating the Experiment
<ol>
	<li>To euthanize the animal, increase isoflurane to 4%. When breathing has slowed, usually in 1-2 min, cut through the sternum with scissors to open the thoracic cavity and expose the heart.</li>
	<li>Grasp the heart with medium forceps and excise it from the body by cutting at the ascending aorta with scissors.</li>
</ol>

<ol>
	<li>Mitchell, G. F., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Changes+in+arterial+stiffness+and+wave+reflection+with+advancing+age+in+healthy+men+and+women+-+The+Framingham+Heart+Study.">Changes in arterial stiffness and wave reflection with advancing age in healthy men and women - The Framingham Heart Study.</a> Hypertension. 43, 1239-1245 (2004).</li><li>Mahmud, A., Feely, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Effect+of+smoking+on+arterial+stiffness+and+pulse+pressure+amplification.">Effect of smoking on arterial stiffness and pulse pressure amplification.</a> Hypertension. 41, 183-187 (2003).</li><li>Lehmann, E. D., Gosling, R. G., Sonksen, P. H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Arterial+wall+compliance+in+diabetes.">Arterial wall compliance in diabetes.</a> Diabet Med. 9, 114-119 (1992).</li><li>Wang, Y. -. X., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Reduction+of+cardiac+functional+reserve+and+elevation+of+aortic+stiffness+in+hyperlipidemic+Yucatan+minipigs+with+systemic+and+coronary+atherosclerosis.">Reduction of cardiac functional reserve and elevation of aortic stiffness in hyperlipidemic Yucatan minipigs with systemic and coronary atherosclerosis.</a> Vasc. Pharmacol. 39, 69-76 (2002).</li><li>Ben-Shlomo, Y., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Aortic+Pulse+Wave+Velocity+Improves+Cardiovascular+Event+Prediction:+An+Individual+Participant+Meta-Analysis+of+Prospective+Data+From+17,635+Subjects.">Aortic Pulse Wave Velocity Improves Cardiovascular Event Prediction: An Individual Participant Meta-Analysis of Prospective Data From 17,635 Subjects.</a> J. Am. Coll. Cardiol. 63, 636-646 (2014).</li><li>Mitchell, G. F., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Arterial+stiffness+and+cardiovascular+events:+the+Framingham+Heart+Study.">Arterial stiffness and cardiovascular events: the Framingham Heart Study.</a> Circulation. 121, 505-511 (2010).</li><li>Mattace-Raso, F. U., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Arterial+stiffness+and+risk+of+coronary+heart+disease+and+stroke:+the+Rotterdam+Study.">Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study.</a> Circulation. 113, 657-663 (2006).</li><li>Laurent, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Aortic+stiffness+is+an+independent+predictor+of+all-cause+and+cardiovascular+mortality+in+hypertensive+patients.">Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients.</a> Hypertension. 37, 1236-1241 (2001).</li><li>Fung, Y. C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=.">.</a> Biomechanics: Mechanical Properties of Living Tissues. , (1993).</li><li>Shadwick, R. E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Mechanical+design+in+arteries.">Mechanical design in arteries.</a> J Exp Biol. 202, 3305-3313 (1999).</li><li>Gasser, T. C., Ogden, R. W., Holzapfel, G. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Hyperelastic+modelling+of+arterial+layers+with+distributed+collagen+fibre+orientations.">Hyperelastic modelling of arterial layers with distributed collagen fibre orientations.</a> Journal of The Royal Society Interface. 3, 15-35 (2006).</li><li>Zieman, S. J., Melenovsky, V., Kass, D. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Mechanisms,+Pathophysiology,+and+Therapy+of+Arterial+Stiffness.">Mechanisms, Pathophysiology, and Therapy of Arterial Stiffness.</a> Arteriosclerosis, Thrombosis, and Vascular Biology. 25, 932-943 (2005).</li><li>Jung, S. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Increased+tissue+transglutaminase+activity+contributes+to+central+vascular+stiffness+in+eNOS+knockout+mice.">Increased tissue transglutaminase activity contributes to central vascular stiffness in eNOS knockout mice.</a> Am. J. Physiol.-Heart Circul. Physiol. 305, 803-810 (2013).</li><li>Santhanam, L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Decreased+S-Nitrosylation+of+Tissue+Transglutaminase+Contributes+to+Age-Related+Increases+in+Vascular+Stiffness.">Decreased S-Nitrosylation of Tissue Transglutaminase Contributes to Age-Related Increases in Vascular Stiffness.</a> Circ. Res. 107, 117-243 (2010).</li><li>Fitch, R. M., Vergona, R., Sullivan, M. E., Wang, Y. X. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Nitric+oxide+synthase+inhibition+increases+aortic+stiffness+measured+by+pulse+wave+velocity+in+rats.">Nitric oxide synthase inhibition increases aortic stiffness measured by pulse wave velocity in rats.</a> Cardiovasc. Res. 51, 351-358 (2001).</li><li>Bergel, D. H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+static+elastic+properties+of+the+arterial+wall.">The static elastic properties of the arterial wall.</a> The Journal of Physiology. 156, 445-457 (1961).</li><li>Leloup, A. J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Applanation+Tonometry+in+Mice:+A+Novel+Noninvasive+Technique+to+Assess+Pulse+Wave+Velocity+and+Arterial+Stiffness.">Applanation Tonometry in Mice: A Novel Noninvasive Technique to Assess Pulse Wave Velocity and Arterial Stiffness.</a> Hypertension. 21, 21 (2014).</li><li>Morrison, T. M., Choi, G., Zarins, C. K., Taylor, C. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Circumferential+and+longitudinal+cyclic+strain+of+the+human+thoracic+aorta:+age-related+changes.">Circumferential and longitudinal cyclic strain of the human thoracic aorta: age-related changes.</a> J Vasc Surg. 49, 1029-1036 (2009).</li><li>Butlin, M., Hammond, A., Lindesay, G., Viegas, K., Avolio, A. P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=In+vitro+and+in+vivo+use+of+vasoactive+agents+in+characterising+aortic+stiffness+in+rats:+testing+the+assumptions.">In vitro and in vivo use of vasoactive agents in characterising aortic stiffness in rats: testing the assumptions.</a> Hypertens. 30, 42 (2012).</li></ol>

The authors have nothing to disclose.

Taking diameter measurements at several pressure increments over a wide range of pressure values is necessary for accurate characterization of the pressure-diameter relationship. The upper and lower pressure limits that can be pharmacologically induced may vary by the experimental group but the ideal range is around 25 mm Hg to 125 mm Hg diastolic and 50 mm Hg to 200 mm Hg systolic. Doses of 360 &#181;g/kg/min PE and 240 &#181;g/kg/min SNP generally elicit the limits of the pressure range. However, doses of PE can be increased to 480 &#181;g/kg/min and SNP to 360 &#181;g/kg/min to verify that the limits have been reached. Working concentrations of PE and SNP can be decreased to achieve finer pressure increments. As the diameter will change with aortic pressure, inducing the same pressure values between animals and experimental groups is not important.
Venous and arterial cannulation can be performed at other locations with the same outcomes. Tail vein cannulation can be challenging because of the small size of the tail vein. Moreover, the tail vein is not readily visible in dark colored mice. The femoral vein can be cannulated as an alternative. This route may be easier since the femoral vein is more accessible. For pressure catheter insertion, besides the femoral artery, the catheter can be inserted through the carotid. The femoral artery is preferable over the carotid artery, however, because the chest region remains intact for the ultrasound imaging. Femoral artery cannulation can be more difficult because the femoral artery is smaller. Using a 1.2 F catheter and introducing the catheter in the proximal femoral artery beneath the abdominal cavity will facilitate the cannulation process. Placing a few drops of a vasodilating agent like lidocaine onto the femoral artery or using a catheter introducer can also help enlarge the vessel to facilitate catheter insertion. The pressure catheter should be handled and used according to the manufacturer&#8217;s instructions.
Location of the catheter within the aorta does not need to be consistent between animals as the pressure drop within the aorta is insignificant. However, placing the catheter in the abdominal aorta may be better to minimize interference with the ultrasound imaging of the thoracic aorta. Some ultrasound mainframes can record pressure real-time with the M-mode trace, thereby giving a pressure measurement for every diameter measured on the M-mode. Unfortunately, because the location where the diameter is measured is not the same location as where pressure is recorded, a lag exists between the pressure recorded at the catheter and the actual pressure in the ascending aorta. As a result, only maximum and minimum diameter measurements can be used for the data analysis.
The primary limitation of this method is the uncertainty in measurement introduced by the aorta shifting in and out of the ultrasound plane during the cardiac cycle. Motion-introduced error is common to all imaging based studies, including MRI and CT. Compensation strategies include using anatomical features to shift the frame of reference with the movement18 and are implemented during data processing. As motion compensation software is not readily available, the investigator has to be vigilant about adjusting the location of the probe to track the shift in location of the aorta as blood pressure rises and decreases. Diameter measurements should also be taken through the center of the aorta. However, determining whether the M-mode recording location is passing through the center can be difficult to judge on the ultrasound image, especially with the aorta shifting positions. The uncertainty introduced by these limitations manifest in the degree of scatter in the data, as evident in Figure 6. Obtaining an image of the cross-section instead of longitudinal axis of the ascending aorta could be a solution. However, obtaining this view can sometimes be more challenging and the resulting M-mode trace can be less clear. The cross-sectional circumference from the B-mode image could be measured instead of the diameter from the M-mode image. However, determining when maximum and minimum circumference has been achieved will be limited by the B-mode frame rate and may be more difficult to judge than on the M-mode.
Making multiple measurements of the pressure-diameter plot and increasing experimental group size can improve accuracy of the data. The pressure-diameter data can be collected from several locations along the chest. This protocol would first be carried out with the probe placed on one location on the chest. The aorta would then be visualized with the probe placed on another location and the protocol repeated.
Vasoactive agents used to modulate blood pressure could potentially affect aortic smooth muscle tone, which in turn would affect stiffness. However, manipulation of aortic pressure by venous return has been shown to produce similar changes in invasively measured PWV as pharmacologic manipulation in rats. These findings demonstrate that infusion of vasoactive drugs act primarily on the peripheral resistance arteries and do not significantly affect aortic smooth muscle tone19.
This protocol can be performed in rats with a few minor modifications. The chest is shaved prior to applying depilatory cream. A commercially available 27 G x &#189;&#8221; catheter is used for drug infusion. The drug doses used to modulate aortic pressure are 40, 80, and 120 &#181;g/kg/min of PE and 40, 80, and 120 &#181;g/kg/min of SNP.
Besides the ascending aorta, regional differences in aortic stiffness can be determined with this protocol. Regional stiffness measured by this approach would be more precise than by PWV as measurements are taken from one location as oppose to two locations for PWV. However, regions along the aorta that can be measured with this technique are limited to those that can be visualized by ultrasound.
Elastic modulus can also be calculated from the data collected by this method if a wall thickness measurement can be obtained. Accurate in vivo measurement of the mouse aorta is limited by the resolution limits of current ultrasound technology. Future improvement of ultrasound technology could make in vivo wall thickness measurement more feasible. As an alternative, thickness measurements can be performed ex vivo. Pressure myography would provide the most accurate measurements because thickness can be measured at each pressure increment.

Increased aortic stiffness is a hallmark of cardiovascular disease. Aging1, smoking2, diabetes3, hyperlipidemia4, and other risk factors of cardiovascular disease have been shown to increase aortic stiffness. Epidemiological studies have further demonstrated aortic stiffness as a powerful independent predictor of the onset of coronary heart disease and stroke, as well as the occurrence of cardiovascular events and mortality5-8. Because of the clinical and public health significance of increased aortic stiffness, current research is focused on understanding the mechanisms underlying the development and progression of vascular stiffness. Great interest therefore exists in developing accurate measures of vascular stiffness in experimental models of cardiovascular disease.
A material&#8217;s stiffness can be characterized by its stress-strain relationship and quantified as elastic modulus. A linear elastic material deforms reversibly and its stress increases proportionally to strain. The aorta and the large arteries are nonlinear elastic bodies: when stretched, the stiffness of the artery does not remain constant but increases with the degree of distension. This nonlinearity in the mechanical properties of large arteries is due to the different stiffness properties of the load bearing elements, namely elastin and collagen, which constitute the vessel wall. Elastin is highly extensible with an elastic modulus of 0.6 MPa. In comparison, collagen is very stiff with an elastic modulus of 1 GPa9. The initial stiffness exhibited by the aorta at lower strain values is attributed to elastin while the high stiffness exhibited at high strain values is due to collagen. Load is transferred from elastin to collagen as the vessel distends and this region of load transferring is where the vascular system operates. Therefore, at physiologic pressures, arterial stiffness depends on the contribution of both elastin and collagen10.
The distribution and orientation of elastin and collagen vary by layer within the arterial wall. In the media, the elastin, collagen, and smooth muscle cells are bundled into tight helices that are layered concentrically. This arrangement allows the artery to resist high loads in the circumferential direction. The adventitia is predominantly collagen with little elastin and the collagen fibers are organized in a net-like fashion. These collagen fibers are wavy in an unstressed state and straighten out as load increases. Stiffness increases as the collagen fibers straighten out, thereby preventing the artery from overstretching and rupturing. Because of the structural organization and varying orientation of the collagen fibers, arteries are anisotropic: the stiffness exhibited depends on if the vessel is stretched longitudinally or circumferentially11. In vivo stiffness is therefore a composite of the aorta&#8217;s longitudinal and circumferential stiffness.
Arterial stiffness is generally quantified in vivo as compliance or pulse wave velocity (PWV). Arterial compliance is defined as C = &#8710;D / &#8710;P where &#8710;D is change in diameter and &#8710;P is the corresponding change in pressure. Lower values of compliance indicate stiffer vessels. Compliance is calculated from the pressure-dimension relationship of the artery and is therefore a direct measure of stiffness. As stiffness is disseminated non uniformly in the vasculature12, compliance should be measured at the same/similar location in each subject to make meaningful comparisons between experimental groups.
The difference between compliance and elastic modulus is that elastic modulus is normalized to the material&#8217;s dimensions. Compliance therefore reflects structural stiffness, whereas elastic modulus reflects material stiffness. With aging, arterial wall thickness increases and elastin/collagen ratio decreases, so both structural stiffness and material stiffness are greater.
Compared to compliance, PWV is an indirect measure of arterial stiffness. PWV is the speed at which a pressure pulse travels along a length of artery and is influenced by the properties of the vessel wall. The Moens-Korteweg equation is used to model the relationship between PWV and elastic modulus: PWV2 = E h / (2 &#961; r) where E is incremental elastic modulus, h is wall thickness, &#961; is blood viscosity, and r is vessel radius. A higher PWV value therefore suggests a stiffer vessel.
Compliance and elastic modulus can be measured experimentally ex vivo on an excised segment of vessel. To determine compliance, the vessel segment is mounted on a pressure myograph13,14. Pressure within the vessel is increased step-wise and the resulting change in diameter is tracked using video microscopy. Compliance is determined from the pressure-diameter data. Incremental elastic modulus can be measured by tensile testing. In these experiments, the vessel is pulled apart step-wise and force-displacement data is collected until the vessel ring breaks. Stress and strain values can be calculated and plotted to determine incremental elastic modulus. These ex vivo approaches can be used to evaluate changes in the passive properties that influence stiffness.
In vivo, in addition to wall content, vascular stiffness is influenced dynamically by smooth muscle tone and blood pressure13,15,16. PWV is the most widely used method for measuring in vivo aortic stiffness in experimental models. PWV can be determined noninvasively using Doppler ultrasound or applanation tonometry17. Pressure pulse is measured at two separate locations and the time required for the pulse to traverse the distance is the pulse wave velocity. Because PWV is measured over a length of aorta, it is an averaged value of stiffness. Large arteries are nonlinear elastic, so stiffness and therefore PWV will vary with arterial pressure. A higher PWV value could therefore arise from increased stiffness or elevated pressure. PWV values therefore must be normalized to blood pressure to derive conclusions about the vessel&#8217;s stiffness. Measurement methods that incorporate the influence of blood pressure with the passive properties of the vascular wall and the effects of vasoactive mediators that alter tone would yield a physiologically relevant index of arterial stiffness. This approach is implemented by measuring PWV invasively using a catheter with two pressure sensors separated at a fixed distance13. This dual pressure catheter is inserted into the aorta and vasoactive drugs, such as phenylephrine or sodium nitroprusside, are infused intravenously through a venous catheter to raise and lower arterial pressure.
This protocol describes a method to determine aortic stiffness in vivo from its pressure-dimension relationship in a mouse model. This approach offers several advantages over the invasive PWV measurement. Stiffness indices, such as compliance, can be calculated from the pressure-dimension data collected by this procedure. Moreover, this technique allows for measurement of local aortic stiffness because stiffness is measured from a single location. This approach is particularly useful in measuring ascending aortic stiffness as the short length of this region makes a PWV measurement difficult to obtain. Research interest exists specifically in the ascending aorta because its mechanical properties influence the perfusion of the coronary circulation and the cardiac response to vascular dysfunction.
To measure the pressure-diameter relationship of the aorta in vivo, the ascending aorta is visualized and its diameter is measured by ultrasound imaging. Aortic blood pressure is measured invasively with a pressure catheter. Blood pressure is changed incrementally by intravenous infusion of vasoactive drugs. Phenylephrine constricts blood vessels and is used to raise aortic pressure. Sodium nitroprusside dilates blood vessels and is used to lower aortic pressure. Systolic and diastolic aortic diameters and corresponding aortic pressures are measured for each pressure increment. Compliance can be calculated from the pressure-diameter data collected.

<table><tbody><tr><td>Equipment</td><td></td><td></td><td></td></tr><tr><td>High-resolution ultrasound machine</td><td>Visual Sonics</td><td>Vevo2100</td><td></td></tr><tr><td>13-24 MHz transducer</td><td>Visual Sonics</td><td>MS250</td><td>Used for imaging rats</td></tr><tr><td>22-55 MHz transducer</td><td>Visual Sonics</td><td>MS550D</td><td>Used for imaging mice</td></tr><tr><td>Imaging Station</td><td>Visual Sonics</td><td>Imagine Station 1</td><td></td></tr><tr><td>1.2F Pressure catheter</td><td>Transonic</td><td>FTH-1211B-0018</td><td></td></tr><tr><td>SP200 pressure control unit</td><td>Transonic</td><td>FFS-095-DP01</td><td></td></tr><tr><td>Standard Infusion Only Harvard Pump 11 Plus syringe pump</td><td>Harvard Apparatus</td><td>702208</td><td></td></tr><tr><td>Isoflurane vaporizer</td><td>VetEquip</td><td>911103</td><td></td></tr><tr><td>Induction chamber</td><td>VetEquip</td><td>941443</td><td></td></tr><tr><td>100% O&lt;sub&gt;2&lt;/sub&gt;</td><td>Airgas</td><td>OX USP200</td><td></td></tr><tr><td>Single Stage Brass 0-50 psi General Purpose Cylinder Regulator CGA540</td><td>Airgas</td><td>Y11215B540</td><td></td></tr><tr><td>Stereo Boom Stand Microscope</td><td>National Optical</td><td>420-BMSQ</td><td></td></tr><tr><td>Fiber optic illuminator &amp;amp; light pipe</td><td>Cole Palmer</td><td>EW-41500-50</td><td></td></tr><tr><td>Supplies</td><td></td><td></td><td></td></tr><tr><td>30G x 1/2&quot; BD PrecisionGlide Needle</td><td>BD</td><td>305106</td><td>For tail vein cannulation in mice</td></tr><tr><td>Polyethylene Tubing PE10</td><td>Becton Dickinson</td><td>427401</td><td>For tail vein cannulation in mice</td></tr><tr><td>27G x 1/2&quot; Surfloe winged infusion set</td><td>Terumo</td><td>SV*27EL</td><td>For tail vein cannulation in rats</td></tr><tr><td>Signa Gel Electrode Gel</td><td>Parker</td><td>15-25</td><td>Use for ECG recording</td></tr><tr><td>Aquasonic Clear Ultrasound Gel</td><td>Parker</td><td>03-08</td><td>Use for ultrasound</td></tr><tr><td>1ml Sub-Q Syringes, 26G x 5/8&quot;</td><td>BD</td><td>309597</td><td></td></tr><tr><td>Nair</td><td>Nair</td><td></td><td>Depilatory cream</td></tr><tr><td>Histoacryl</td><td>TissueSeal</td><td>TS1050071FP</td><td>Tissue glue</td></tr><tr><td>Braided Silk Suture 6-0</td><td>Teleflex</td><td>104-S</td><td></td></tr><tr><td>Dumostar P55 fine forceps</td><td>Roboz</td><td>RS-4984</td><td></td></tr><tr><td>Microscissors</td><td>WPI</td><td>501839</td><td></td></tr><tr><td>Fine scissors</td><td>FST</td><td>14060-11</td><td></td></tr><tr><td>Medium forceps</td><td>Ted Pella</td><td>5665</td><td></td></tr><tr><td>Hemostatic forceps</td><td>Roboz</td><td>RS-7131</td><td></td></tr><tr><td>Non-sterile cotton gauze sponge</td><td>Fisherbrand</td><td>22-362-178</td><td></td></tr><tr><td>Cotton tipped applicators</td><td>Oritan</td><td>803-WC</td><td></td></tr><tr><td>Label tape</td><td>Fisherbrand</td><td>15-901-20</td><td></td></tr><tr><td>Drugs</td><td></td><td></td><td></td></tr><tr><td>Sodium chloride</td><td>Sigma Aldrich</td><td>S7653</td><td></td></tr><tr><td>R-Phenylephrine hydrochloride</td><td>Sigma Aldrich</td><td>P6126</td><td></td></tr><tr><td>Sodium nitroprusside dihydrate</td><td>Sigma Aldrich</td><td>71778</td><td></td></tr><tr><td>Software</td><td></td><td></td><td></td></tr><tr><td>Prism</td><td>GraphPad</td><td></td><td></td></tr><tr><td>Excel</td><td>Microsoft</td><td></td><td></td></tr></tbody></table>

measuring ascending aortic stiffness in vivo in mice using ultrasound

We present a protocol for measuring in vivo aortic stiffness in mice using high-resolution ultrasound imaging. Aortic diameter is measured by ultrasound and aortic blood pressure is measured invasively with a solid-state pressure catheter. Blood pressure is raised then lowered incrementally by intravenous infusion of vasoactive drugs phenylephrine and sodium nitroprusside. Aortic diameter is measured for each pressure step to characterize the pressure-diameter relationship of the ascending aorta. Stiffness indices derived from the pressure-diameter relationship can be calculated from the data collected. Calculation of arterial compliance is described in this protocol.
This technique can be used to investigate mechanisms underlying increased aortic stiffness associated with cardiovascular disease and aging. The technique produces a physiologically relevant measure of stiffness compared to ex vivo approaches because physiological influences on aortic stiffness are incorporated in the measurement. The primary limitation of this technique is the measurement error introduced from the movement of the aorta during the cardiac cycle. This motion can be compensated by adjusting the location of the probe with the aortic movement as well as making multiple measurements of the aortic pressure-diameter relationship and expanding the experimental group size.

A longitudinal image of the left ventricle and ascending aorta is captured on B-mode, as shown in Figure 1. Alternatively, a longitudinal image of only the aorta can be obtained, as in Figure 2. The movement of the aortic wall during the cardiac cycle appears as two white lines on the M-mode, as shown in Figure 3. The aortic lumen is the area in between the lines. Aortic pressure is modulated by infusion of vasoactive drugs. PE raises the aortic pressure, as shown in Figure 4A, and SNP lowers pressure, as shown in Figure 4B. M-mode is recorded when blood pressure plateaus, 1 min after the start of infusion. Aortic pressure is changed incrementally through changing the dose of the drug administered, as shown in Figure 5. Dose of drug is controlled through the rate of infusion. All drug doses are in &#181;g/kg/min. Maximum and minimum diameters are measured from the M-mode, shown in Figure 3. These diameters correspond to the systolic and diastolic aortic pressures recorded by the pressure catheter.
Systolic and diastolic diameter and pressure values of three cardiac cycles are measured at baseline and for each PE and SNP dose. The standard deviation between three diameter measurements at one drug dose ranges from 0.01 mm to 0.04 mm. Aortic diameter can be plotted against its corresponding aortic pressure to illustrate the pressure-diameter relationship, as shown in Figure 6A.
These pressure-diameter values are used to calculate aortic compliance. Arterial compliance is calculated by
C = (Dsys&#8211; Ddia) / (Psys&#8211; Pdia)(1)
where Dsys and Ddia are systolic and diastolic diameters and Psys and Pdia are systolic and diastolic pressures. Compliance and mean aortic pressure (MAP) are calculated at baseline and for each PE and SNP dose. Compliance is plotted against MAP to demonstrate the pressure-dependency of stiffness. Because of the nonlinear elastic behavior of the aorta, compliance decreases with increasing MAP, as seen in Figure 6B.
<img alt="Figure 1" src="/files/ftp_upload/52200/52200fig1highres.jpg" /> 
Figure 1: Longitudinal view of ascending aorta on B-mode. Diameter measurements are taken from a longitudinal image of the ascending aorta leaving the left ventricle. LV: left ventricle; PA: pulmonary artery; AA: ascending aorta. Visualization of the pulmonary artery depends on the probe placement. Aortic diameter is measured distal to the aortic valve. Frequency of the probe used to capture this image is 40 MHz.
<img alt="Figure 2" src="/files/ftp_upload/52200/52200fig2highres.jpg" /> 
Figure 2: Alternate view of ascending aorta on B-mode. The ascending aorta is featured more prominently and the left ventricle and heart walls are less distinct. AA: ascending aorta; LV: left ventricle. Frequency of probe used to record this image is 40 MHz.
<img alt="Figure 3" src="/files/ftp_upload/52200/52200fig3highres.jpg" /> 
Figure 3: Aorta visualized on M-mode. Aortic diameter is measured from the M-mode image. The movement of the aortic wall appears as two wavy lines. The space in between the two lines is the aortic lumen. Systolic and diastolic aortic diameters of three cardiac cycles are measured from the M-mode. In this image, aortic pressure recorded by the pressure catheter, ECG signal, and respiratory cycle are displayed in red, green, and yellow on the M-mode. Probe frequency used to record this image is 40 MHz and the acquisition sweep speed is 1,200 Hz.
<img alt="Figure 4" src="/files/ftp_upload/52200/52200fig4highres.jpg" /> 
Figure 4: Changing aortic pressure incrementally. Aortic pressure is changed incrementally by the dose of drug infused. Drug dose is modulated by the infusion rate. All doses are in &#181;g/kg/min.
<img alt="Figure 5" src="/files/ftp_upload/52200/52200fig5highres.jpg" /> 
Figure 5: Modulating aortic pressure with vasoactive drugs. Aortic pressure is increased with infusion of vasoconstrictor phenylephrine (PE) and decreased with infusion of vasodilator sodium nitroprusside (SNP). Aortic pressure plateaus 1 min after the start of the drug infusion. M-mode of the aortic diameter is recorded at the plateau. (A) shows the rise in aortic pressure with 360 &#181;g/kg/min PE infusion. (B) shows the decrease in aortic pressure with 240 &#181;g/kg/min SNP infusion. The time the infusion is begun and the time the M-mode is recorded are labeled on the traces.&#160;Aortic pressure is changed incrementally by the dose of drug infused. Drug dose is modulated by the infusion rate. All doses are in &#181;g/kg/min.
<img alt="Figure 6" src="/files/ftp_upload/52200/52200fig6highres.jpg" /> 
Figure 6: Diameter vs. pressure and compliance vs. mean aortic pressure plots. Aortic diameter can be plotted against its corresponding aortic pressure to show the pressure-diameter relationship (A). Compliance can be calculated for each pressure increment and plotted against the mean aortic pressure (MAP) to show the pressure dependency of aortic stiffness (B).

Watch this Scientific Journal Video about Measuring Ascending Aortic Stiffness In Vivo in Mice Using Ultrasound at JoVE.com

Measuring Ascending Aortic Stiffness In Vivo in Mice Using Ultrasound

We describe a technique for measuring aortic stiffness from its pressure-diameter relationship in vivo in mice. Aortic diameter is recorded by ultrasound and aortic pressure is measured invasively with a solid-state pressure catheter. Blood pressure is changed incrementally and the resulting diameter is measured.

Measuring Ascending Aortic Stiffness In Vivo in Mice Using Ultrasound

We present a protocol for measuring in vivo aortic stiffness in mice using high-resolution ultrasound imaging. Aortic diameter is measured by ultrasound ...

measuring-ascending-aortic-stiffness-in-vivo-in-mice-using-ultrasound

Research

JoVE Journal

Medicine

15.9K Views.  Johns Hopkins University. We describe a technique for measuring aortic stiffness from its pressure-diameter relationship in vivo in mice. Aortic diameter is recorded by ultrasound and aortic pressure is measured invasively with a solid-state pressure catheter. Blood pressure is changed incrementally and the resulting diameter is measured.

Video: Measuring Ascending Aortic Stiffness In Vivo in Mice Using Ultrasound

Murine Echocardiography and Ultrasound Imaging

Rodent models of cardiac pathophysiology represent a valuable research tool to investigate mechanism of disease as well as test new therapeutics.1 Echocardiography provides a powerful, non-invasive tool to serially assess cardiac morphometry and function in a living animal.2 However, using this technique on mice poses unique challenges owing to the small size and rapid heart rate of these animals.3 Until recently, few ultrasound systems were capable of performing quality echocardiography on mice, and those generally lacked the image resolution and frame rate necessary to obtain truly quantitative measurements. Newly released systems such as the VisualSonics Vevo2100 provide new tools for researchers to carefully and non-invasively investigate cardiac function in mice. This system generates high resolution images and provides analysis capabilities similar to those used with human patients. Although color Doppler has been available for over 30 years in humans, this valuable technology has only recently been possible in rodent ultrasound.4,5 Color Doppler has broad applications for echocardiography, including the ability to quickly assess flow directionality in vessels and through valves, and to rapidly identify valve regurgitation. Strain analysis is a critical advance that is utilized to quantitatively measure regional myocardial function.6 This technique has the potential to detect changes in pathology, or resolution of pathology, earlier than conventional techniques. Coupled with the addition of three-dimensional image reconstruction, volumetric assessment of whole-organs is possible, including visualization and assessment of cardiac and vascular structures. Murine-compatible contrast imaging can also allow for volumetric measurements and tissue perfusion assessment.

This video demonstrates use of a rail-mounted high-frequency ultrasound probe to perform echocardiography on an anesthetized mouse. The methods describe both conventional two-dimensional and M-mode measurements of cardiac function in addition to newer, more powerful tools such as color Doppler, strain analysis, as well as general and targeted contrast imaging.

Rodent models of cardiac pathophysiology represent a valuable research tool to investigate mechanism of disease as well as test new therapeutics.1  ...

Ultrasound Based Assessment of Coronary Artery Flow and Coronary Flow Reserve Using the Pressure Overload Model in Mice

Transthoracic Doppler echocardiography (TTDE) is a clinically useful, noninvasive tool for studying coronary artery flow velocity and coronary flow reserve (CFR) in humans. Reduced CFR is accompanied by marked intramyocardial and pericoronary fibrosis and is used as an indication of the severity of dysfunction. This study explores, step-by-step, the real-time changes measured in the coronary flow velocity, CFR and systolic to diastolic peak velocity (S/D) ratio in the setting of an aortic banding model in mice. By using a Doppler transthoracic imaging technique that yields reproducible and reliable data, the method assesses changes in flow in the septal coronary artery (SCA), for a period of over two weeks in mice, that previously either underwent aortic banding or thoracotomy. 
During imaging, hyperemia in all mice was induced by isoflurane, an anesthetic that increased coronary flow velocity when compared with resting flow. All images were acquired by a single imager. Two ratios, (1) CFR, the ratio between hyperemic and baseline flow velocities, and (2) systolic (S) to diastolic (D) flow were determined, using a proprietary software and by two independent observers. Importantly, the observed changes in coronary flow preceded LV dysfunction as evidenced by normal LV mass and fractional shortening (FS). 
The method was benchmarked against the current gold standard of coronary assessment, histopathology. The latter technique showed clear pathologic changes in the coronary artery in the form of peri-coronary fibrosis that correlated to the flow changes as assessed by echocardiography. 
The study underscores the value of using a non-invasive technique to monitor coronary circulation in mouse hearts. The method minimizes redundant use of research animals and demonstrates that advanced ultrasound-based indices, such as CFR and S/D ratios, can serve as viable diagnostic tools in a variety of investigational protocols including drug studies and the study of genetically modified strains.

Coronary flow reserve (CFR) is useful for assessment of myocardial oxygen demand and evaluation of cardiovascular risk. This study establishes a step-by-step transthoracic Doppler echocardiographic (TTDE) method for longitudinal monitoring of the changes in CFR, as measured from coronary artery in mice, under the experimental pressure overload of aortic banding.

Transthoracic Doppler echocardiography (TTDE) is a clinically useful, noninvasive tool for studying coronary artery flow velocity and coronary flow ...

Assessment of Cardiac Morphological and Functional Changes in Mouse Model of Transverse Aortic Constriction by Echocardiographic Imaging

Transverse aortic constriction (TAC) in mice has been used as a valuable model to study mechanisms of cardiac hypertrophy and heart failure1. A reliable noninvasive method is essential to assess real-time cardiac morphological and functional changes in animal models of heart disease. Transthoracic echocardiography represents an important tool for noninvasive assessment of cardiac structure and function2. Here we used a high-resolution ultrasound imaging system to monitor myocardial remodeling and heart failure progression over time in a mouse model of TAC. B-mode, M-mode, and Doppler imaging were used to precisely assess cardiac hypertrophy, ventricular dilatation, and functional deterioration in mice following TAC. Color and pulse wave (PW) Doppler imaging was used to noninvasively measure pressure gradient across the aortic constriction created by TAC and to assess transmitral blood flow in mice. Thus transthoracic echocardiographic imaging provides comprehensive noninvasive measurements of cardiac dimensions and function in mouse models of heart disease.

The goal of this protocol is to noninvasively assess cardiac structural and functional changes in a mouse model of heart disease created by transverse aortic constriction, using B- and M-mode echocardiography and color/pulse wave Doppler imaging.

Transverse aortic constriction (TAC) in mice has been used as a valuable model to study mechanisms of cardiac hypertrophy and heart failure1. A reliable ...

Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice

The aim of this manuscript and accompanying video is to provide an overview of the methods and approaches used for imaging heart valve function in rodents, with detailed descriptions of the appropriate methods for anesthesia, the echocardiographic windows used, the imaging planes and probe orientations for image acquisition, the methods for data analysis, and the limitations of emerging technologies for the evaluation of cardiac and valvular function. Importantly, we also highlight several future areas of research in cardiac and heart valve imaging that may be leveraged to gain insights into the pathogenesis of valve disease in preclinical animal models. We propose that using a systematic approach to evaluating cardiac and heart valve function in mice can result in more robust and reproducible data, as well as facilitate the discovery of previously underappreciated phenotypes in genetically-altered and/or physiologically-stressed mice.

This protocol provides a detailed description of the echocardiographic approach for comprehensive phenotyping of heart and heart valve function in mice.

The aim of this manuscript and accompanying video is to provide an overview of the methods and approaches used for imaging heart valve function in ...

Ultrasound-based Pulse Wave Velocity Evaluation in Mice

Arterial stiffness can be evaluated by calculating pulse wave velocity (PWV), i.e., the speed with which the pulse wave travels in a conduit vessel. This parameter is being increasingly investigated in small rodent models in which it is used for assessing alterations in vascular function related to particular genotypes/treatments or for characterizing cardiovascular disease progression. This protocol describes an image processing algorithm which leads to non-invasive arterial PWV measurement in mice using ultrasound (US) images only. The proposed technique has been used to assess abdominal aorta PWV in mice and evaluate its age-associated changes.
Abdominal aorta US scans are obtained from mice under gaseous anesthesia using a specific US device equipped with high-frequency US probes. B-mode and Pulse-Wave Doppler (PW-Doppler) images are analyzed in order to obtain diameter and mean velocity instantaneous values, respectively. For this purpose, edge detection and contour tracking techniques are employed. The single-beat mean diameter and velocity waveforms are time aligned and combined in order to achieve the diameter-velocity (lnD-V) loop. PWV values are obtained from the slope of the linear part of the loop, which corresponds to the early systolic phase.
With the present approach, anatomical and functional information about the mouse abdominal aorta can be non-invasively achieved. Requiring the processing of US images only, it may represent a useful tool for the non-invasive characterization of different arterial sites in the mouse in terms of elastic properties. The application of the present technique can be easily extended to other vascular districts, such as the carotid artery, thus providing the possibility to obtain a multi-site arterial stiffness assessment.

Arterial stiffness represents a key factor in cardiovascular disease and pulse wave velocity (PWV) can be considered as a surrogate index for arterial stiffness. This protocol describes an image processing algorithm for calculating PWV in mice based on ultrasound image processing that is applicable at different arterial sites.

Arterial stiffness can be evaluated by calculating pulse wave velocity (PWV), i.e., the speed with which the pulse wave travels in a conduit vessel. This ...

Ultrasound Assessment of Flow-Mediated Dilation of the Brachial and Superficial Femoral Arteries in Rats

Arterial vasodilation to increases in wall shear rate is indicative of vascular endothelial function. In humans, the non-invasive measurement of endothelial function can be achieved by employing the flow-mediated dilation technique, typically performed in the brachial or superficial femoral artery. Briefly, a blood pressure cuff placed distal to an ultrasound probe is inflated to a suprasystolic pressure, which results in limb ischemia. After 5 min of occlusion the cuff is deflated, resulting in reactive hyperemia and increases in wall shear rate that signal vasodilatory molecules to be released from the endothelium eliciting vasodilation. Despite the thousands of studies performing flow-mediated dilation in humans, surprisingly, no studies have performed this technique non-invasively in living rats. Considering the recent shift in focus to translational research, the establishment of guidelines for non-invasive measurement of flow-mediated dilation in rats and other rodents would be extremely valuable. In the following article, a protocol is presented for the non-invasive measurement of flow-mediated dilation in brachial and superficial femoral arteries of rats, as those sites are most commonly measured in humans.

Non-invasive assessment of endothelial function in humans can be determined by the flow-mediated dilation technique. Although thousands of studies have used this technique, no study has performed this technique non-invasively in rats. The following article describes non-invasive measurement of flow-mediated dilation in the brachial and superficial femoral arteries of rats.

Arterial vasodilation to increases in wall shear rate is indicative of vascular endothelial function. In humans, the non-invasive measurement of ...

Minimally Invasive Transverse Aortic Constriction in Mice

Minimally invasive transverse aortic constriction (MTAC) is a more desirable method for the constriction of the transverse aorta in mice than standard open-chest transverse aortic constriction (TAC). Although transverse aortic constriction is a highly functional method for the induction of high pressure in the left ventricle, it is a more difficult and lengthy procedure due to its use of artificial ventilation with tracheal intubation. TAC is oftentimes also less survivable, as the newer method, MTAC, neither requires the cutting of the ribs and intercostal muscles nor tracheal intubation with a ventilation setup. In MTAC, as opposed to a thoracotomy to access to the chest cavity, the aortic arch is reached through a midline incision in the anterior neck. The thyroid is pulled back to reveal the sternal notch. The sternum is subsequently cut down to the second rib level, and the aortic arch is reached simply by separating the connective tissues and thymus. From there, a suture can be wrapped around the arch and tied with a spacer, and then the sternal cut and skin can be closed. MTAC is a much faster and less invasive way to induce left ventricular hypertension and enables the possibility for high-throughput studies. The success of the constriction can be verified using high-frequency trans-thoracic echocardiography, particularly color Doppler and pulsed-wave Doppler, to determine the flow velocities of the aortic arch and left and right carotid arteries, the dimension of the blood vessels, and the left ventricular function and morphology. A successful constriction will also trigger significant histopathological changes, such as cardiac muscle cell hypertrophy with interstitial and perivascular fibrosis. Here, the procedure of MTAC is described, demonstrating how the resulting flow changes in the carotid arteries can be examined with echocardiography, gross morphology, and histopathological changes in the heart.

Minimally invasive transverse aortic constriction (MTAC) conserves the essentials of regular transverse aortic constriction (TAC) while eliminating the use of a ventilator with tracheal intubation. It proves to be a highly desirable method for high-throughput studies on left ventricular overload, particularly in translational studies.

Minimally invasive transverse aortic constriction (MTAC) is a more desirable method for the constriction of the transverse aorta in mice than standard ...

Measurement of Pulse Propagation Velocity, Distensibility and Strain in an Abdominal Aortic Aneurysm Mouse Model

An abdominal aortic aneurysm (AAA) is defined as a localized dilation of the abdominal aorta that exceeds the maximal intraluminal diameter (MILD) by 1.5 times of its original size. Clinical and experimental studies have shown that small aneurysms may rupture, while a subpopulation of large aneurysms may remain stable. Thus, in addition to the measurement of intraluminal diameter of the aorta, knowledge of structural traits of the vessel wall may provide important information to assess the stability of the AAA. Aortic stiffening has recently emerged as a reliable tool to determine early changes in the vascular wall. Pulse propagation velocity (PPV) along with the distensibility and radial strain are highly useful ultrasound-based methods relevant for assessing aortic stiffness. The primary purpose of this protocol is to provide a comprehensive technique for the use of ultrasound imaging system to acquire images and analyze the structural and functional properties of the aorta as determined by MILD, PPV, distensibility and radial strain.

This manuscript describes a detailed protocol for using high frequency ultrasound imaging to measure luminal diameter, pulse propagation velocity, distensibility and radial strain on a mouse model of abdominal aortic aneurysm.

An abdominal aortic aneurysm (AAA) is defined as a localized dilation of the abdominal aorta that exceeds the maximal intraluminal diameter (MILD) by 1.5 ...

Immunology and Infection

Ultrasound Imaging of the Thoracic and Abdominal Aorta in Mice to Determine Aneurysm Dimensions

Contemporary high-resolution ultrasound instruments have sufficient resolution to facilitate the measurement of mouse aortas. These instruments have been widely used to measure aortic dimensions in mouse models of aortic aneurysms. Aortic aneurysms are defined as permanent dilations of the aorta, which occur most frequently in the ascending and abdominal regions. Sequential measurements of aortic dimensions by ultrasound are the principal approach for assessing the development and progression of aortic aneurysms in vivo. Although many reported studies used ultrasound imaging to measure aortic diameters as a primary endpoint, there are confounding factors, such as probe position and cardiac cycle, that may impact the accuracy of data acquisition, analysis, and interpretation. The purpose of this protocol is to provide a practical guide on the use of ultrasound to measure the aortic diameter in a reliable and reproducible manner. This protocol introduces the preparation of mice and instruments, the acquisition of appropriate ultrasound images, and data analysis.

Ultrasound imaging has become a common modality to determine the luminal dimensions of thoracic and abdominal aortic aneurysms in mice. This protocol describes the procedure to acquire reliable and reproducible two-dimensional ultrasound images of the ascending and abdominal aorta in mice.

Contemporary high-resolution ultrasound instruments have sufficient resolution to facilitate the measurement of mouse aortas. These instruments have been ...

Measuring the Stiffness of Ex Vivo Mouse Aortas Using Atomic Force Microscopy

Arterial stiffening is a significant risk factor and biomarker for cardiovascular disease and a hallmark of aging. Atomic force microscopy (AFM) is a versatile analytical tool for characterizing viscoelastic mechanical properties for a variety of materials ranging from hard (plastic, glass, metal, etc.) surfaces to cells on any substrate. It has been widely used to measure the stiffness of cells, but less frequently used to measure the stiffness of aortas. In this paper, we will describe the procedures for using AFM in contact mode to measure the ex vivo elastic modulus of unloaded mouse arteries. We describe our procedure for isolation of mouse aortas, and then provide detailed information for the AFM analysis. This includes step-by-step instructions for alignment of the laser beam, calibration of the spring constant and deflection sensitivity of the AFM probe, and acquisition of force curves. We also provide a detailed protocol for data analysis of the force curves.

Measuring the Stiffness of Ex Vivo Mouse Aortas Using Atomic Force Microscopy

We present detailed protocols for isolation of aortas from mouse and measurement of their elastic modulus using atomic force microscopy.

Arterial stiffening is a significant risk factor and biomarker for cardiovascular disease and a hallmark of aging. Atomic force microscopy (AFM) is a ...

Measuring Ascending Aortic Stiffness In Vivo in Mice Using Ultrasound

Summary

Explore More Videos

Chapters in this video

Murine Echocardiography and Ultrasound Imaging

Ultrasound Based Assessment of Coronary Artery Flow and Coronary Flow Reserve Using the Pressure Overload Model in Mice

Assessment of Cardiac Morphological and Functional Changes in Mouse Model of Transverse Aortic Constriction by Echocardiographic Imaging

Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice

Ultrasound-based Pulse Wave Velocity Evaluation in Mice

Ultrasound Assessment of Flow-Mediated Dilation of the Brachial and Superficial Femoral Arteries in Rats

Minimally Invasive Transverse Aortic Constriction in Mice

Measurement of Pulse Propagation Velocity, Distensibility and Strain in an Abdominal Aortic Aneurysm Mouse Model

Ultrasound Imaging of the Thoracic and Abdominal Aorta in Mice to Determine Aneurysm Dimensions

Measuring the Stiffness of Ex Vivo Mouse Aortas Using Atomic Force Microscopy